Document:

Exhibit

EXHIBIT 10.6 

AMENDMENT TO EMPLOYMENT AGREEMENT - MANI MOHINDRU

THIS AMENDMENT (the “Amendment”) is made as of March 7, 2017 between Curis, Inc., a Delaware corporation (the “Company”), and Mani Mohindru, Ph.D. (the “Employee”).

WHEREAS, Employee’s employment with the Company is subject to the terms and conditions of an employment agreement currently in effect by and between Employee and the Company, dated as of February 29, 2016 (the “Employment Agreement”); and
WHEREAS, the Compensation Committee of the Company’s Board of Directors has determined it appropriate to increase the severance that would be potentially payable to the Employee in certain terminations of employment following a change in control.
NOW THEREFORE, in consideration of the mutual covenants and agreements contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Employee and the Company hereby agree to amend the Employment Agreement as follows:
1.Clause (iii) in Section 4(d)(ii) is revised by replacing “within ninety (90) days following the initial existence of the condition” with “no later than 30 days following the last day of the cure period in clause (ii).”

2.Section 5(b) is revised by deleting the words “(or if the base salary was reduced within 12 months following a Change in Control Event from the level in effect immediately before the consummation of that event, the level before such reduction).”

3.Section 5(c) is renumbered Section 5(d) and a new Section 5(c) is inserted to read as follows:  
In the event that, within 12 months following a Change in Control Event, the Employee’s employment terminates as a result of a termination by the Employee for Good Reason, or a termination by the Company or its successor without Cause, in addition to the compensation and benefits described in Section 5(a), the Employee shall receive, reduced by all applicable taxes and withholdings, (i) the Employee’s then base salary (or if the base salary was reduced within 12 months following a Change in Control Event from the level in effect immediately before the consummation of that event, the level before such reduction) paid ratably over a period of 12 months in accordance with the Company’s then current payroll policies and practices, (ii) an amount equal to the full target bonus for the year of termination, and (iii) an amount equal to a portion of the same year’s target bonus, pro-rated to reflect days elapsed from the beginning of the bonus year to the date of termination over 365, with the payments in clauses (ii) and (iii) to be made on or around the date of the first installment of the payments under clause (i).  If severance is due under the proceeding sentence, the Company will also pay any difference between the COBRA premium and the amount the Employee would otherwise be responsible for with respect to the medical and dental coverage elected for a period of 12 months from the date of such termination or as long as the Employee is eligible for and elects to be covered by COBRA, whichever period is shorter. At the end of this period, the Employee is eligible to continue coverage for the balance of the statutory period under COBRA, provided that the Employee pays the COBRA premium. Notwithstanding the foregoing, the Company may end the payment of premiums earlier (but not the Employee’s eligibility for COBRA) if it 

reasonably determines that applicable laws or regulations are reasonably likely to cause the payment of these premiums to trigger taxes or penalties on the Company or other participants or, to the extent the Employee would be taxed on more than the amount of the premiums, to the Employee.  The benefits provided under this Section 5(c) shall be in lieu of any benefits to which the Employee would have otherwise been entitled pursuant to Section 5(b) of this Agreement.
4.Section 5(e), as renumbered, is revised to say “The benefits provided for the Employee under this Agreement shall be the sole payments and benefits for which the Employee shall be eligible at the conclusion of her employment with the Company for any reason (other than as provided under the terms of any equity compensation plans or awards) and shall supersede any and all prior agreements or arrangements for post-termination severance.”

5.Except as specifically amended herein, the Employment Agreement shall remain in full force and effect in accordance with its terms.

IN WITNESS WHEREOF, the parties have executed this Amendment as of the date first written above.

Mani Mohindru, Ph.D. (“Employee”)    Curis, Inc. (the “Company”):

  /s/ Mani Mohindru, Ph.D.              /s/ Ali Fattaey, Ph.D.            
Name:  Ali Fattaey, Ph.D.
Title:    President and CEOExhibit

EXHIBIT 10.8 

AMENDMENT TO EMPLOYMENT AGREEMENT - DAVID TUCK

THIS AMENDMENT (the “Amendment”) is made as of March 7, 2017 between Curis, Inc., a Delaware corporation (the “Company”), and David Tuck, M.D. (the “Employee”).

WHEREAS, Employee’s employment with the Company is subject to the terms and conditions of an employment agreement currently in effect by and between Employee and the Company, dated as of February 29, 2016 (the “Employment Agreement”); and
WHEREAS, the Compensation Committee of the Company’s Board of Directors has determined it appropriate to increase the severance that would be potentially payable to the Employee in certain terminations of employment following a change in control.
NOW THEREFORE, in consideration of the mutual covenants and agreements contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Employee and the Company hereby agree to amend the Employment Agreement as follows:
1.Clause (iii) in Section 4(d)(ii) is revised by replacing “within ninety (90) days following the initial existence of the condition” with “no later than 30 days following the last day of the cure period in clause (ii).”

2.Section 5(b) is revised by deleting the words “(or if the base salary was reduced within 12 months following a Change in Control Event from the level in effect immediately before the consummation of that event, the level before such reduction).”

3.Section 5(c) is renumbered Section 5(d) and a new Section 5(c) is inserted to read as follows:  
In the event that, within 12 months following a Change in Control Event, the Employee’s employment terminates as a result of a termination by the Employee for Good Reason, or a termination by the Company or its successor without Cause, in addition to the compensation and benefits described in Section 5(a), the Employee shall receive, reduced by all applicable taxes and withholdings, (i) the Employee’s then base salary (or if the base salary was reduced within 12 months following a Change in Control Event from the level in effect immediately before the consummation of that event, the level before such reduction) paid ratably over a period of 12 months in accordance with the Company’s then current payroll policies and practices, (ii) an amount equal to the full target bonus for the year of termination, and (iii) an amount equal to a portion of the same year’s target bonus, pro-rated to reflect days elapsed from the beginning of the bonus year to the date of termination over 365, with the payments in clauses (ii) and (iii) to be made on or around the date of the first installment of the payments under clause (i).  If severance is due under the proceeding sentence, the Company will also pay any difference between the COBRA premium and the amount the Employee would otherwise be responsible for with respect to the medical and dental coverage elected for a period of 12 months from the date of such termination or as long as the Employee is eligible for and elects to be covered by COBRA, whichever period is shorter. At the end of this period, the Employee is eligible to continue coverage for the balance of the statutory period under COBRA, provided that the Employee pays the COBRA premium. Notwithstanding the foregoing, the Company may end the payment of premiums earlier (but not the Employee’s eligibility for COBRA) if it 

reasonably determines that applicable laws or regulations are reasonably likely to cause the payment of these premiums to trigger taxes or penalties on the Company or other participants or, to the extent the Employee would be taxed on more than the amount of the premiums, to the Employee.  The benefits provided under this Section 5(c) shall be in lieu of any benefits to which the Employee would have otherwise been entitled pursuant to Section 5(b) of this Agreement.
4.Section 5(e), as renumbered, is revised to say “The benefits provided for the Employee under this Agreement shall be the sole payments and benefits for which the Employee shall be eligible at the conclusion of his employment with the Company for any reason (other than as provided under the terms of any equity compensation plans or awards) and shall supersede any and all prior agreements or arrangements for post-termination severance.”

5.Except as specifically amended herein, the Employment Agreement shall remain in full force and effect in accordance with its terms.

IN WITNESS WHEREOF, the parties have executed this Amendment as of the date first written above.

David Tuck, M.D. (“Employee”)        Curis, Inc. (the “Company”):

  /s/ David Tuck, M.D.              /s/ Ali Fattaey, Ph.D.            
Name:  Ali Fattaey, Ph.D.
Title:    President and CEOExhibit

EXHIBIT 10.21

[Form of Online Cover Sheet]

Notice of Grant of Stock Options and Option Agreement
Curis, Inc.
ID: 04-3505116
4 Maguire Road
Lexington, MA 02421

	
			
	Name
	Option Number:
	CU000000

	Address
	Plan:
	Non

	City, State, Zip Code
	ID:
	000-00-0000

Effective 00/00/0000 (“Grant Date”), you have been granted a(n) Incentive Stock Option to buy a specified number of shares (“Shares”) of CURIS INC. (the “Company”) stock at a specified price per share (“Exercise Price”). The details of your stock option grant are as follows:
	
		
	

Date of Grant
	

[                 ]

	Vesting Commencement Date
	[                 ]

	Exercise Price Per Share
	[$               ]

	Total Number of Shares Granted
	[                 ]

	Total Exercise Price
	[$               ]

	Term/Expiration Date
	[                 ]

Shares in each period will become fully vested on the dates shown below:
	
			
	Shares
	Vest Type
	Full Vest

	 
	On Vest Date
	 

	 
	[Quarterly]
	 

By clicking “Accept”, you and the Company agree that these options are granted under and governed by the terms and conditions of the Company's Incentive Stock Option Agreement, all of which are attached and made a part of this document.

Terms and Conditions of Incentive Stock Option Agreement

1.Grant of Option.
This agreement evidences the grant by Curis, Inc., a Delaware corporation (the “Company”), on the Grant Date to the Participant, an employee of the Company, of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s Amended and Restated 2010 Stock Incentive Plan, as amended (the “Plan”), the Shares of common stock, $0.01 par value per share, of the Company (“Common Stock”) at the Per Share Exercise Price.  Unless earlier terminated, this option shall expire on the Expiration Date (or the “Final Exercise Date”).
It is intended that the option evidenced by this agreement shall be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”).  Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.
2.    Vesting Schedule.
This option will become exercisable (“vest”) as to 25% of the original number of Shares on the first anniversary of the Grant Date and as to an additional 6.25% of the original number of Shares at the end of each successive quarterly period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date. 
The right of exercise shall be cumulative so that to the extent the option is not exercised in any period to the maximum extent permissible it shall continue to be exercisable, in whole or in part, with respect to all Shares for which it is vested until the earlier of the Final Exercise Date or the termination of this option under Section 3 hereof or the Plan.
3.    Exercise of Option.
(a)    Form of Exercise.  Each election to exercise this option shall be in writing, signed by the Participant, and received by the Company at its principal office, accompanied by this agreement, and payment in full in the manner provided in the Plan.  The Participant may purchase less than the number of shares covered hereby, provided that no partial exercise of this option may be for any fractional share or for fewer than ten whole shares.
(b)    Continuous Relationship with the Company Required.  Except as otherwise provided in this Section 3, this option may not be exercised unless the Participant, at the time he or she exercises this option, is, and has been at all times since the Grant Date, an employee or officer of, or consultant or advisor to, the Company or any parent or subsidiary of the Company as defined in Section 424(e) or (f) of the Code (an “Eligible Participant”).

(c)    Termination of Relationship with the Company.  If the Participant ceases to be an Eligible Participant for any reason, then, except as provided in paragraphs (d) and (e) below, the right to exercise this option shall terminate three months after such cessation (but in no event after the Final Exercise Date), provided that this option shall be exercisable only to the extent that the Participant was entitled to exercise this option on the date of such cessation.  Notwithstanding the foregoing, if the Participant, prior to the Final Exercise Date, violates the non-competition or confidentiality provisions of any employment contract, confidentiality and nondisclosure agreement or other agreement between the Participant and the Company, the right to exercise this option shall terminate immediately upon written notice to the Participant from the Company describing such violation. 
(d)    Exercise Period Upon Death or Disability.  If the Participant dies or becomes disabled (within the meaning of Section 22(e)(3) of the Code) prior to the Final Exercise Date while he or she is an Eligible Participant and the Company has not terminated such relationship for “cause” as specified in paragraph (e) below, this option shall be exercisable, within the period of one year following the date of death or disability of the Participant, by the Participant (or in the case of death by an authorized transferee), provided that this option shall be exercisable only to the extent that this option was exercisable by the Participant on the date of his or her death or disability, and further provided that this option shall not be exercisable after the Final Exercise Date.
(e)    Termination for Cause.  If, prior to the Final Exercise Date, the Participant’s employment is terminated by the Company for Cause (as defined below), the right to exercise this option shall terminate immediately upon the effective date of such termination of employment.  If the Participant is party to an employment, consulting or severance agreement with the Company that contains a definition of “cause” for termination of employment or other relationship, “Cause” shall have the meaning ascribed to such term in such agreement.  Otherwise, “Cause” shall mean any (i) willful failure by the Participant, which failure is not cured within 30 days of written notice to the Participant from the Company, to perform his or her material responsibilities to the Company or (ii) willful misconduct by the Participant which affects the business reputation of the Company.  The Participant’s employment shall be considered to have been terminated for Cause if the Company determines, within 30 days after the Participant’s resignation, that termination for Cause was warranted.
4.    Tax Matters.
(a)    Withholding.  No Shares will be issued pursuant to the exercise of this option unless and until the Participant pays to the Company, or makes provision satisfactory to the Company for payment of, any federal, state or local withholding taxes required by law to be withheld in respect of this option.  
(b)    Disqualifying Disposition.  If the Participant disposes of Shares acquired upon exercise of this option within two years from the Grant Date or one year after such Shares were acquired pursuant to exercise of this option, the Participant shall notify the Company in writing of such disposition.

5.    Transfer Restrictions.  This option may not be sold, assigned, transferred, pledged or otherwise encumbered by the Participant, either voluntarily or by operation of law, except by will or the laws of descent and distribution, and, during the lifetime of the Participant, this option shall be exercisable only by the Participant.
6.    Provisions of the Plan. This option is subject to the provisions of the Plan (including the provisions relating to amendments to the Plan), a copy of which is furnished to the Participant with this option.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00268-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00268-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00268-of-00352.parquet"}]]